Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCopenhagen University Hospital at Herlev
About this trial
Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.
Eligibility criteria
Qualifiers
Patient with cancer or osteoporosis, treated with antiresorptive treatment.
The patients should have sufficient compliance, this includes willingness to have the planned assessments
The patient should have an expected life span at enrollment of at least 2 years.
The local bone quality and quantity should be sufficient for implant insertion without bone augmentation and is classified according to the classification by Cawood & Howell 1988.
Disqualifiers
> 10 cigarettes daily
HbA1c > 53 mmol/mol
Poor oral hygiene
Poor general condition: ECOG score 3 or 4.
Trial design
Treatments tested in this trial
- Dental implant surgery
- Prosthetic treatment
Treatment groups
225 Participants
are divided into 9 treatment groups9
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Copenhagen University Hospital at Herlev
Lead sponsor
Amgen
Collaborator
Institut Straumann AG
Collaborator
Source ClinicalTrials.gov